These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851 [TBL] [Abstract][Full Text] [Related]
5. The economic implications of influenza vaccination for adults with asthma. Trogdon JG; Nurmagambetov TA; Thompson HF Am J Prev Med; 2010 Nov; 39(5):403-10. PubMed ID: 20965377 [TBL] [Abstract][Full Text] [Related]
9. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis. Rothberg MB; Rose DN Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults. Muennig PA; Khan K Clin Infect Dis; 2001 Dec; 33(11):1879-85. PubMed ID: 11692300 [TBL] [Abstract][Full Text] [Related]
12. [Pharmaco-economics of anti-influenza vaccinations]. Jahnz-Rózyk K Pol Merkur Lekarski; 2003 Jun; 14(84):679-81. PubMed ID: 14524303 [TBL] [Abstract][Full Text] [Related]
13. [Influenza vaccination: the advantages are still underestimated]. Beyer WE; Masurel N Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1779-80. PubMed ID: 6415500 [No Abstract] [Full Text] [Related]
14. Influenza--the forgotten vaccination. Martin DJ; Schoub BD S Afr Med J; 1997 Jul; 87(7):869-71. PubMed ID: 9259719 [No Abstract] [Full Text] [Related]
15. [Cost-effectiveness of prophylaxis and treatment of influenza]. Rychlik R; Heinen-Kammerer T; Rusche H; Piercy J; Scuffham P; Zöllner Y Dtsch Med Wochenschr; 2003 Oct; 128(43):2267-70. PubMed ID: 14574642 [No Abstract] [Full Text] [Related]
16. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older. Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ Am J Prev Med; 2006 Jul; 31(1):72-9. PubMed ID: 16777545 [TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia. Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537 [TBL] [Abstract][Full Text] [Related]
18. Influenza vaccination cost effective in U.S. adults. Geriatrics; 2006 Feb; 61(2):14. PubMed ID: 16502520 [No Abstract] [Full Text] [Related]
19. Influenza vaccines provide diminished protection but are cost-saving in older adults. Deans GD; Stiver HG; McElhaney JE J Intern Med; 2010 Feb; 267(2):220-7. PubMed ID: 20175868 [TBL] [Abstract][Full Text] [Related]